Skip to content

Horizon Therapeutics Public Ltd Co: filings

Every Horizon Therapeutics Public Ltd Co annual and quarterly report in the SEC record with the published financial measures it tagged, 51 filings, each linked to its SEC index.

Filing record ends 2023-08-08

The latest filing in this captured record is a 10-Q filed 2023-08-08. No later filing is in the SEC companyfacts record captured on 2026-09-22. Horizon Therapeutics Public Ltd Co may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-08-08fiscal Q2 2023551520000950170-23-039388
10-Q2023-05-03fiscal Q1 2023541080000950170-23-016886
10-K2023-03-01fiscal FY 2022601510000950170-23-005337
10-Q2022-11-02fiscal Q3 2022561560000950170-22-020973
10-Q2022-08-03fiscal Q2 2022551510001564590-22-027613
10-Q2022-05-04fiscal Q1 2022551110001564590-22-017669
10-K2022-03-01fiscal FY 2021591510001564590-22-007863
10-Q2021-11-03fiscal Q3 2021561560001564590-21-053729
10-Q2021-08-04fiscal Q2 2021551510001564590-21-040498
10-Q2021-05-05fiscal Q1 2021511030001564590-21-023631
10-K2021-02-24fiscal FY 2020571950001564590-21-007818
10-Q2020-11-02fiscal Q3 2020541530001564590-20-049438
10-Q2020-08-05fiscal Q2 2020511340001564590-20-036432
10-Q2020-05-06fiscal Q1 2020501000001564590-20-021536
10-K2020-02-26fiscal FY 2019582000001564590-20-006575
10-Q2019-11-06fiscal Q3 2019541510001564590-19-040666
10-Q2019-08-07fiscal Q2 2019501340001564590-19-029652
10-Q2019-05-08fiscal Q1 2019501000001564590-19-016824
10-K2019-02-27fiscal FY 2018522230001564590-19-004668
10-K2019-02-27fiscal FY 2018522230001564590-19-004667
10-Q2018-11-07fiscal Q3 2018531430001564590-18-027742
10-Q2018-08-08fiscal Q2 2018491260001564590-18-020184
10-Q2018-05-09fiscal Q1 201842860001564590-18-012115
10-K2018-02-28fiscal FY 2017501660001564590-18-003661
10-Q2017-11-06fiscal Q3 2017421110001564590-17-021618
10-Q2017-08-07fiscal Q2 2017461260001564590-17-015817
10-Q2017-05-08fiscal Q1 201741840001564590-17-009236
10-K2017-02-27fiscal FY 2016491650001564590-17-002491
10-Q2016-11-07fiscal Q3 2016451250001564590-16-027808
10-Q2016-08-08fiscal Q2 2016451250001564590-16-023136
10-Q2016-05-09fiscal Q1 201640820001564590-16-018433
10-K2016-02-29fiscal FY 2015491550001564590-16-013652
10-Q2015-11-06fiscal Q3 2015451240001564590-15-009832
10-Q2015-08-07fiscal Q2 2015451260001193125-15-281984
10-Q2015-05-08fiscal Q1 201540820001193125-15-178423
10-K/A2015-03-02fiscal FY 2014461450001193125-15-070952
10-K2015-02-27fiscal FY 2014461430001193125-15-067257
10-Q2014-11-06fiscal Q3 2014451240001193125-14-399728
10-Q2014-08-07fiscal Q2 2014421140001193125-14-299376
10-Q2014-05-09fiscal Q1 201444870001193125-14-190991
10-K2014-03-13fiscal FY 2013481510001193125-14-096677
10-Q2013-11-08fiscal Q3 2013441160001564590-13-001105
10-Q2013-08-09fiscal Q2 2013441170001193125-13-327964
10-Q2013-05-10fiscal Q1 201342840001193125-13-212425
10-K2013-03-18fiscal FY 2012491530001193125-13-111071
10-Q2012-11-13fiscal Q3 2012441140001193125-12-465501
10-Q2012-08-10fiscal Q2 2012441150001193125-12-348701
10-Q2012-05-10fiscal Q1 201240800001193125-12-223515
10-K2012-03-23fiscal FY 201139950001193125-12-129945
10-Q2011-11-14fiscal Q3 201137930001193125-11-309655
10-Q2011-09-02fiscal Q2 201138780001193125-11-240251

Inspect the source

Entity
Horizon Therapeutics Public Ltd Co / CIK 0001492426
Captured
SEC response SHA-256
62e78f64be52de0e4dcb73846bd3986cbdaed618a34c1c09596d3b36ed738f76

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001492426.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))